August 26th 2025
Where to find members of our editorial board at this year's European Society of Retina Specialists Congress
Scleral buckling or PPV can treat rhegmatogenous RD in BD
May 22nd 2014Scleral buckling or pars plana vitrectomy (PPV) can be used to treat rhegmatogenous retinal detachment (RD) associated with Beh?et's disease (BD), according to researchers in the Department of Ophthalmology, Zagazig University, Egypt.
RPE-specific mice suitable for gene activation and inactivation
May 9th 2014A tetracycline-inducible Cre mouse line created specifically to study the retinal pigment epithelium (RPE) is suitable for Cre/lox-based gene activation and inactivation in adult RPE, which makes the mice suitable for long-term studies requiring conditional gene targeting.
Ranibizumab may improve retinal function and structure in DME
February 28th 2014Treatment of diabetic macular oedema (DME) with ranibizumab may improve retinal function and structure, according to researchers from the National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and University College, London Institute of Ophthalmology.
Direction affects distribution of MSS
February 1st 2014The membranes found on the retinal surface can cause visual symptoms in various conditions and a patient's vision can often be improved with surgical removal of these membranes, according to Mr Mahmut Dogramaci (The Lister Surgicentre, Lister Hospital, Stevenage, UK).
High-risk patients benefit from home monitoring
December 6th 2013The Home Monitoring of the Eye (HOME) study, conducted in AREDS2 clinical centres, has demonstrated that patients at high-risk of developing choroidal neovascularization (CNV) - the neovascular or wet phase of AMD - benefit from using the ForeseeHome monitoring device (Notal Vision).
Encouraging results for dry AMD treatment revealed
December 4th 2013Roche has announced additional encouraging results of a phase II study with lampalizumab to treat patients with geographic atrophy (GA). The MAHALO study data was presented during the Retina subspeciality day at AAO 2013 in New Orleans, Louisiana, USA.
Protein from fat-derived stem cells may prevent retinal damage
November 28th 2013Progranulin, a protein found in fat-derived stem cells, may reverse and perhaps prevent age-related, light-induced retinal damage, according to results from a study done in a mouse model by researchers from Gifu Pharmaceutical University and Gifu University, Japan.
Diabetic retinopathy affects nearly all young patients with type 1 diabetes
November 14th 2013One in three young Danish patients with type 1 diabetes mellitus progressed to proliferative diabetic retinopathy, and two in three had 2-step progression despite their young age, according to study results recently published in the November 2013 issue of Acta Diabetologica. In addition, these researchers from Denmark found that after 30-years? duration of diabetes, the presence of diabetic retinopathy was almost universal.
Pazopanib shows therapeutic potential as treatment for AMD
November 6th 2013Oral pazopanib - in a dose of 15 mg/d - is well tolerated and may improve mean best-corrected visual acuity (BCVA), central retinal lesion thickness and central retinal thickness in as little as 1 month of treatment in some patients with age-related macular degeneration (AMD), according to recent study results.
Ocriplasmin receives NICE recommendation for treatment of vitreomacular traction
October 30th 2013The National Institute for Health and Care Excellence (NICE) has recommended ocriplasmin (Jetrea) as a clinically effective and cost-effective treatment option for patients suffering from vitreomacular traction, including that associated with macular hole of ? 400 ?m when an epiretinal membrane is absent, or adults with vitreomacular traction and severe symptoms, when an epiretinal membrane and macular hole are both absent.